Cataract
Conditions
Interventions
This is a randomized, controlled, double-blind clinical trial with two arms. At least forty-eight individuals meeting the eligibility criteria will be randomly allocated to receive two different inter
Sponsors
Hospital Oftalmológico de Brasília
Hospital Oftalmológico de Brasília
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients undergoing phacoemulsification at HOBrasil, Salvador, Bahia; at least 18 years old; of both genders
Exclusion criteria
Exclusion criteria: Patients under 18 years of age; pregnant patients; patients with chronic pain syndrome; patients with hypersensitivity to any of the tested medications or the topical anesthesia used; patients with communication difficulties (significant hearing loss, speech impairments, aphasias); patients with physical status determined by the American Society of Anesthesiologists classification of III-VI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine whether ketamine combined with a benzodiazepine mitigates patient pain and maintains an adequate level of consciousness for performing phacoemulsification, in a manner not inferior to fentanyl combined with a benzodiazepine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analyze the adverse effects caused by the use of each sedative (ketamine combined with a benzodiazepine and fentanyl combined with a benzodiazepine).;Determine patient satisfaction with the use of each sedative using a Likert scale (1-5).;Determine the pain experienced by the patient with the use of each sedative using a Likert scale (1-5).;Determine the surgeon's satisfaction with the use of each sedative using the SURG-TLX questionnaire. | — |
Countries
Brazil
Contacts
Public ContactAdriano Faneli
Instituto de Olhos Freitas
Outcome results
None listed